Evidence map›Paper›PMID 35545034›Full record

ArticleCell reports2022

Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy.

Bhaskar Saha, Michelle Salemi, Geneva L Williams, Seeun Oh, Michael L Paffett, Brett Phinney, Michael A Mandell

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Regulation and roles of mammalian mitophagy.Nature reviews. Molecular cell biology · 2026
    Review
  2. Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. TBK1 is ubiquitinated by TRIM5α to assemble mitophagy machinery.bioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Diversity of mitophagy pathways at a glance.Journal of cell science · 2022
    Article
  11. Impacts of arsenic on Rad18 and translesion synthesis.Toxicology and applied pharmacology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bhaskar SahaDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Michelle SalemiUC Davis Genome Center, University of California Davis, Davis, CA 95616, USA.
Geneva L WilliamsBiomedical Sciences Graduate Program, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Seeun OhDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Michael L PaffettFluorescence Microscopy and Cell Imaging Shared Resource, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131, USA.
Brett PhinneyUC Davis Genome Center, University of California Davis, Davis, CA 95616, USA.
Michael A MandellDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA; Autophagy, Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: mmandell@salud.unm.edu.
University of New Mexico · USUniversity of California, Davis · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Monica Rosas Lemus · 2017 to 2026
$24.9M
Cellular responses to retroviral capsid recognitionR01AI155746 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MANDELL, MICHAEL AARON · 2021 to 2025
$2.1M
Phinney - Orbitrap Fusion ETDS10OD021801 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PHINNEY, BRETT S · 2016 to 2016
$600k
NCI NIH HHS P30 CA118100NIAID NIH HHS R01 AI155746NIGMS NIH HHS P20 GM121176NIH HHS S10 OD021801
6 · The paper itself

Abstract

The protein TRIM5α has multiple roles in antiretroviral defense, but the mechanisms underlying TRIM5α action are unclear. Here, we employ APEX2-based proteomics to identify TRIM5α-interacting partners. Our proteomics results connect TRIM5 to other proteins with actions in antiviral defense. Additionally, they link TRIM5 to mitophagy, an autophagy-based mode of mitochondrial quality control that is compromised in several human diseases. We find that TRIM5 is required for Parkin-dependent and -independent mitophagy pathways where TRIM5 recruits upstream autophagy regulators to damaged mitochondria. Expression of a TRIM5 mutant lacking ubiquitin ligase activity is unable to rescue mitophagy in TRIM5 knockout cells. Cells lacking TRIM5 show reduced mitochondrial function under basal conditions and are more susceptible to immune activation and death in response to mitochondrial damage than are wild-type cells. Taken together, our studies identify a homeostatic role for a protein previously recognized exclusively for its antiviral actions.

Indexed as

HIV InfectionsMitophagyAntiviral Restriction FactorsAutophagyHIVHumansProteinsTripartite Motif ProteinsUbiquitin-Protein LigasesAntiviral Restriction FactorsProteinsTRIM5 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesAPEX2autophagyCP: Cell biologyCP: ImmunologyER-mitochondria contact siteHIV-1inflammationmitochondrial metabolismproteomicsTRIM5αtripartite motifULK1 complex

Identifiers

PMID35545034
PMCPMC9136943
OpenAlexW4280567188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.